230.265 Kentucky Equine Drug Research Council.
571 words·~3 min read·
/ky/chapter-230/230-265A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)There is hereby created a panel, to be known as the Kentucky Equine Drug
Research Council, to advise the corporation on the conduct of equine drug
research and testing commissioned by the Kentucky Horse Racing and
Gaming Corporation.
(b)The council shall consist of nine
(9)members appointed by the Governor. It is
recommended that the Governor appoint one
(1)person from each of the
following groups, organizations, or professions:
1. A veterinarian, selected from a list of three
(3)submitted by the
Kentucky Association of Equine Veterinarians;
2. A horseman, selected from a list of three
(3)submitted by the Kentucky
division of the Horsemen's Benevolent and Protective Association;
3. A pharmacologist, selected from a list of three
(3)submitted by the
University of Kentucky;
4. A Thoroughbred breeder, selected from a list of three
(3)submitted by
the Kentucky Thoroughbred Owners and Breeders, Inc.;
5. A legislator, selected from a list of three
(3)submitted by the Legislative
Research Commission;
6. A representative of a licensed racing association, chosen by the
Governor;
7. A member of the harness racing industry, selected from a list of three
submitted by the chairman of the Kentucky Horse Racing and Gaming
Corporation;
8. A member selected from a list of three
(3)submitted by the Kentucky
Harness Horsemen's Association; and
9. A member of the Kentucky Horse Racing and Gaming Corporation,
selected from a list of three
(3)submitted by the chairman of the
Kentucky Horse Racing and Gaming Corporation, to serve as chairman.
(c)The council shall meet at the call of the chairman, a majority of the council, or
at the request of the corporation. Members shall serve at the pleasure of their
respective sponsoring organizations and shall receive no compensation for
serving.
(2)The Kentucky Equine Drug Research Council shall:
(a)Review equine drug research and testing research being conducted at the
University of Kentucky, or with state funds;
(b)Review and report to the corporation on drug research and testing research
being conducted elsewhere;
(c)Advise the corporation and make recommendations for establishing an
effective drug regulatory policy for Kentucky racing; and
(d)Report to the General Assembly any needed changes regarding the regulation
of drugs in horse racing in the Commonwealth of Kentucky.
(a)The funds received by the corporation pursuant to KRS 138.510 shall be used
for financing:
1. Drug research;
2. Testing research;
3. Equine medical research;
4. Equine health research issues; and
5. Any regulatory or administrative activity of the corporation that is
related to the research and issues described in subparagraphs 1. to 4. of
this paragraph. Any expenditure under this subsection shall relate to the
racing industry in Kentucky.
(b)In authorizing expenditures, the council and the corporation shall give funding
priority to the activities described in this subsection which will take place, or
are proposed to take place, in Kentucky over similar activities taking place
outside Kentucky. However, expenditures under this subsection in furtherance
of activities taking place outside Kentucky may be approved if the council and
the corporation determine that those expenditures will contribute to
improvement in Kentucky's racing industry and to the development of a useful
knowledge base relating to the subjects expressed in paragraph (a)1. to 5. of
this subsection.
(c)The money received under this subsection shall be in addition to any funds
appropriated to the corporation for these purposes in the executive budget.